---
figid: PMC2773299__WJG-14-6601-g002
figlink: /pmc/articles/PMC2773299/figure/F2/
number: F2
caption: 'Schematic representations of the activated RAS-MAPK, RASSF1A/NORE1A, and
  Dab2IP/ASK1 pathways, iNOS signalling, and FOXM1-related pathways involved in the
  dysregulation of cell growth and apoptosis in HCC. Active Ha-RAS (GTP-RAS) triggers
  the MAPK pathway leading to activation of ERK1/2. Active ERK can down-regulate DUSP1
  by phosphorylation at ser296 allowing the formation of the SKP2/CSK1/DUSP1 complex,
  which facilitates DUSP1 ubiquitination and proteasomal degradation. In addition,
  ERK may further contribute to DUSP1 proteolysis via induction of its target FOXM1,
  leading to transcriptional activation of SKP2 and CKS1. These mechanisms result
  in decreased inhibition of ERK by DUSP1 (blunt arrow). Moreover, FOXM1 favors the
  growth of neoplastic cells by targeting genes involved in G2 ← M transition, genomic
  instability, angiogenesis, NF-κB activation, and anti-apoptosis. iNOS activates
  IKK that allows proteasomal degradation of the NF-κB inhibitor, IkB-α. This results
  in NF-κB activation. iNOS also activates Ha-RAS, thus triggering the MAPK pathway
  leading to activation of ERK1/2. NF-κB activation by ERK may occur through AURORA-A
  (AURKA) which inhibits IkB-α. NF-κB activates various antiapoptotic genes (XIAP,
  cIAP1, BCL-xL) and inhibits the proapoptotic gene JNK. The inhibition of RAS activation
  by DAB2IP leads to the activation of ASK1, whereas active RAS favors the formation
  of the RASSF1-NORE1A complex. Both the ASK1 and RASSF1-NORE1A complexes trigger
  pro-apoptotic pathways. ASK1: Apoptosis signal-regulating kinase 1; BCL-Xl: BCL2-related
  protein, long isoform; CDC37: Cell division cycle 37; CKS1: CDC28 protein kinase
  1b; cIAP: Iinhibitor-of-apoptosis protein 1; DAB2: Disabled homolog 2; DAB2IP: DAB2-interacting
  protein; DUSP1: Dual-specificity phosphatase 1; EPO: Erythropoietin; ERK: Extracellular
  signal-regulated kinase; GLI1: Glioblastoma associated oncogene 1; HIF-1α: Hypoxia-inducible
  factor 1 α; HSP90: Heat shock protein 90; HXK II: Hexokinase II; IKK: Inhibitor
  of kB kinase; iNOS: Inducible nitric oxide synthase; MST1: Mammalian sterile twenty
  kinase 1; NEK2: NIMA-related kinase 2; NF-κB: Nuclear factor-κB; NORE1A: Novel RAS
  effector 1A; RASSF1A: RAS association domain family 1A; RKIP: RAF kinase inhibitory
  protein; SKP2: S-phase kinase-associated protein 2; VEGF-α: Vascular endothelial
  growth factor α; XIAP: Inhibitor of apoptosis, X-linked. Pointed and blunt arrows
  indicate activation and inhibition, respectively.'
pmcid: PMC2773299
papertitle: Interaction of major genes predisposing to hepatocellular carcinoma with
  genes encoding signal transduction pathways influences tumor phenotype and prognosis.
reftext: Francesco Feo, et al. World J Gastroenterol. 2008 Nov 21;14(43):6601-6615.
pmc_ranked_result_index: '182003'
pathway_score: 0.9377904
filename: WJG-14-6601-g002.jpg
figtitle: Schematic representations of the activated RAS-MAPK, RASSF1A/NORE1A, and
  Dab2IP/ASK1 pathways, iNOS signalling, and FOXM1-related pathways involved in the
  dysregulation of cell growth and apoptosis in HCC
year: '2008'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
ndex: 4c6abcf2-df07-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2773299__WJG-14-6601-g002.html
  '@type': Dataset
  description: 'Schematic representations of the activated RAS-MAPK, RASSF1A/NORE1A,
    and Dab2IP/ASK1 pathways, iNOS signalling, and FOXM1-related pathways involved
    in the dysregulation of cell growth and apoptosis in HCC. Active Ha-RAS (GTP-RAS)
    triggers the MAPK pathway leading to activation of ERK1/2. Active ERK can down-regulate
    DUSP1 by phosphorylation at ser296 allowing the formation of the SKP2/CSK1/DUSP1
    complex, which facilitates DUSP1 ubiquitination and proteasomal degradation. In
    addition, ERK may further contribute to DUSP1 proteolysis via induction of its
    target FOXM1, leading to transcriptional activation of SKP2 and CKS1. These mechanisms
    result in decreased inhibition of ERK by DUSP1 (blunt arrow). Moreover, FOXM1
    favors the growth of neoplastic cells by targeting genes involved in G2 ← M transition,
    genomic instability, angiogenesis, NF-κB activation, and anti-apoptosis. iNOS
    activates IKK that allows proteasomal degradation of the NF-κB inhibitor, IkB-α.
    This results in NF-κB activation. iNOS also activates Ha-RAS, thus triggering
    the MAPK pathway leading to activation of ERK1/2. NF-κB activation by ERK may
    occur through AURORA-A (AURKA) which inhibits IkB-α. NF-κB activates various antiapoptotic
    genes (XIAP, cIAP1, BCL-xL) and inhibits the proapoptotic gene JNK. The inhibition
    of RAS activation by DAB2IP leads to the activation of ASK1, whereas active RAS
    favors the formation of the RASSF1-NORE1A complex. Both the ASK1 and RASSF1-NORE1A
    complexes trigger pro-apoptotic pathways. ASK1: Apoptosis signal-regulating kinase
    1; BCL-Xl: BCL2-related protein, long isoform; CDC37: Cell division cycle 37;
    CKS1: CDC28 protein kinase 1b; cIAP: Iinhibitor-of-apoptosis protein 1; DAB2:
    Disabled homolog 2; DAB2IP: DAB2-interacting protein; DUSP1: Dual-specificity
    phosphatase 1; EPO: Erythropoietin; ERK: Extracellular signal-regulated kinase;
    GLI1: Glioblastoma associated oncogene 1; HIF-1α: Hypoxia-inducible factor 1 α;
    HSP90: Heat shock protein 90; HXK II: Hexokinase II; IKK: Inhibitor of kB kinase;
    iNOS: Inducible nitric oxide synthase; MST1: Mammalian sterile twenty kinase 1;
    NEK2: NIMA-related kinase 2; NF-κB: Nuclear factor-κB; NORE1A: Novel RAS effector
    1A; RASSF1A: RAS association domain family 1A; RKIP: RAF kinase inhibitory protein;
    SKP2: S-phase kinase-associated protein 2; VEGF-α: Vascular endothelial growth
    factor α; XIAP: Inhibitor of apoptosis, X-linked. Pointed and blunt arrows indicate
    activation and inhibition, respectively.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - CHUK
  - SKP2
  - NRAS
  - CDC37
  - HRAS
  - POLD1
  - PEBP1
  - MAPK8
  - HSP90AB1
  - IKBKB
  - HSP90B1
  - RAF1
  - YWHAQ
  - BCL2L1
  - CDC25B
  - GLI1
  - HIF1A
  - TRAP1
  - FOXM1
  - BIRC2
  - IKBKG
  - MAPK9
  - NFKBIA
  - VEGFA
  - NFKB1
  - EP300
  - NEK2
  - MAPK1
  - DUSP1
  - MAP3K5
  - DAB2
  - BIRC5
  - XIAP
  - DAB2IP
  - AURKA
  - MAPK3
  - EPO
  - MAPK10
  - MST1
  - Cancer
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: SKP2
  symbol: SKP2
  source: hgnc_symbol
  hgnc_symbol: SKP2
  entrez: '6502'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: CDC37
  symbol: CDC37
  source: hgnc_symbol
  hgnc_symbol: CDC37
  entrez: '11140'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: CDC2
  symbol: CDC2
  source: hgnc_alias_symbol
  hgnc_symbol: POLD1
  entrez: '5424'
- word: RKIP
  symbol: RKIP
  source: hgnc_alias_symbol
  hgnc_symbol: PEBP1
  entrez: '5037'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: RAF1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
- word: BCL-xL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: CDC25B
  symbol: CDC25B
  source: hgnc_symbol
  hgnc_symbol: CDC25B
  entrez: '994'
- word: GLI1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: FOXM1
  symbol: FOXM1
  source: hgnc_symbol
  hgnc_symbol: FOXM1
  entrez: '2305'
- word: CIAP1
  symbol: c-IAP1
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC2
  entrez: '329'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: IKB-a
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: VEGF-a
  symbol: VEGF-A
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: p300
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: NEK2
  symbol: NEK2
  source: hgnc_symbol
  hgnc_symbol: NEK2
  entrez: '4751'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: DUSP1
  symbol: DUSP1
  source: hgnc_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: ASK1
  symbol: ASK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K5
  entrez: '4217'
- word: DAB2
  symbol: DAB2
  source: hgnc_symbol
  hgnc_symbol: DAB2
  entrez: '1601'
- word: SURVIVIN
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: XIAP
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: DAB2IP
  symbol: DAB2IP
  source: hgnc_symbol
  hgnc_symbol: DAB2IP
  entrez: '153090'
- word: AURKA
  symbol: AURKA
  source: hgnc_symbol
  hgnc_symbol: AURKA
  entrez: '6790'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: EPO
  symbol: EPO
  source: hgnc_symbol
  hgnc_symbol: EPO
  entrez: '2056'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MST1
  symbol: MST1
  source: hgnc_symbol
  hgnc_symbol: MST1
  entrez: '4485'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2773299__F2
redirect_from: /figures/PMC2773299__F2
figtype: Figure
---
